featured
4 Gy Versus 24 Gy Radiotherapy for Follicular and Marginal Zone Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
4 Gy Versus 24 Gy Radiotherapy for Follicular and Marginal Zone Lymphoma (FoRT): Long-Term Follow-Up of a Multicentre, Randomised, Phase 3, Non-Inferiority Trial
Lancet Oncol 2021 Feb 01;[EPub Ahead of Print], P Hoskin, B Popova, O Schofield, C Brammer, M Robinson, AM Brunt, K Madhavan, T Illidge, E Gallop-Evans, I Syndikus, L Clifton-Hadley, AA KirkwoodFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.